Related Experiment Videos
Abnormal regional hypermethylation in cancer cells
1Johns Hopkins Oncology Center, Johns Hopkins University School of Medicine, Baltimore, Maryland 21231.
AIDS Research and Human Retroviruses
|May 1, 1992
Summary
Cancer progression involves altered DNA methylation patterns, with initial increases in DNA methylating capacity followed by widespread hypomethylation and regional hypermethylation. These changes drive chromatin alterations and genetic instability, crucial for malignant phenotype emergence.
Area of Science:
- Oncology
- Epigenetics
- Molecular Biology
Background:
- Solid tumor progression, including colon cancer, is associated with significant epigenetic alterations.
- DNA methylation patterns undergo dynamic changes during tumor development, impacting gene expression and chromosomal stability.
Purpose of the Study:
- To review a model explaining the interplay between DNA methylation, chromatin changes, and genetic instability during tumor progression.
- To propose molecular events initiating these dynamics in pre-neoplastic and cancer cells.
Main Methods:
- Review of existing data and models on DNA methylation and tumor progression.
- Conceptual model illustrating the balance of DNA methyltransferase (MTase) activity, cell cycle regulation, and DNA replication.
Main Results:
- Increased cellular DNA methylating capacity is observed in early stages of solid tumor hyperplasia.
- Tumor progression is characterized by widespread DNA hypomethylation alongside regional hypermethylation, particularly at CpG islands.
- These methylation shifts correlate with chromatin changes, gene silencing, and structural chromosome alterations, contributing to genetic instability.
Conclusions:
- Altered DNA methylation patterns and chromatin changes form a cycle that drives tumor progression and malignant phenotype.
- Dysregulation of DNA methyltransferase activity and its interaction with DNA replication forks may initiate these aberrant methylation patterns.
- Further research into these molecular events could reveal key steps in tumor progression and identify therapeutic targets.